Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124

Section 6

Remission — performance standard

Cite as Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124, s. 6 · current to July 24, 2025 · regulation last amended May 31, 2025

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) If the Minister determines that the performance standard has not been met in relation to a fee that is payable under this Order, remission is granted to the person that must pay the fee (a) of an amount equal to 25% of the fee; or (b) of an amount equal to 25% of the amount that is payable, in the case where remission is granted of part of the fee under any other provision of this Order. (2) Subsection (1) does not apply to a fee for the examination of (a) an application or submission referred to in this Order in respect of which a joint or parallel review is conducted by the Minister and a foreign regulatory authority; (b) an application for a licence that is filed under section 32 of the Medical Devices Regulations if (i) the medical device to which the application relates includes a component that is a drug, and (ii) the Minister has made a decision in respect of the application to issue or amend a medical device licence under section 36 of those Regulations, or to refuse to issue or amend such a licence under section 38 of those Regulations; or (c) the following: (i) a new drug submission for a public health emergency drug if subsection C.08.002(2.3) of the Food and Drug Regulations applies to that submission, or (ii) a supplement to any new drug submission if subsection C.08.003(7) of those Regulations applies to that supplement.
Read the Fees in Respect of Drugs and Medical Devices Order on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.